The Lundquist Institute
Jonathan Acevedo is a Ph.D. student at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center since October 2021. Prior experience includes serving as a Chemical Dependence Technician at Park Avenue Center, where responsibilities involved medication supervision and care coordination. As a Lead Researcher at the University of St. Thomas from June 2020 to October 2021, Jonathan led a research project on the effects of ketamine on behavior in mice and developed proficiency in various lab techniques. Previous roles include coaching youth soccer and working as a Research Assistant at the University of St. Thomas, contributing to a study on methamphetamine's effects, which led to a publication. Jonathan holds a Bachelor's of Science in Neuroscience from the University of St. Thomas, completed in 2021.
This person is not in any teams
The Lundquist Institute
The Lundquist Institute, formerly the Los Angeles Biomedical Research Institute (LA BioMed), is an engine of innovation with a global reach and a 67-year reputation of improving and saving lives. With its new medical research building, its state-of-the-art incubator, “BioLabs at The Lundquist,” existing laboratory and support infrastructure, and a 15-acre tech park in the planning stages, The Lundquist Institute is poised to serve as a hub for the Los Angeles area’s burgeoning biotech scene. The research institute has over 100 principal investigators (PhDs, MDs, and MD/PhDs) working on more than 600 research studies, including therapies for numerous orphan diseases, and is responsible for three FDA-approved drugs including the first approved treatment for sickle cell disease in 20 years.